Clinical Trial Logistics Strategies for Maximizing Efficiency, Safety and Regulatory Compliance Explored by Sanofi-Aventis, Pfizer, AstraZeneca, Schering Plough, FDA, DHS and Global BioPharm Solutions

PHILADELPHIA--(BUSINESS WIRE)--Organized by Pharma IQ, a division of IQPC, the Clinical Trials Logistics conference will be held December 7-9, 2009, at the Ritz-Carlton in Philadelphia, PA (www.clinicaltrialslogistics.com).

“If you actually take a look at just the regulatory requirements, they are taking in the vicinity of 44 weeks from the time you start putting together the regulatory documents to the time you can actually ship clinical supplies into the country.”

In today’s drug development climate, clinical supply professionals face unique risk mitigation issues including complying with regulations, evaluating cost-effective distribution processes, shipping between research labs or hospitals and international shipping.

“Clinical supply is consistently getting more complex,” says Steve Jacobs, President of Global BioPharm Solutions and former President of Bilcare Global Clinical Supplies, and a featured speaker at the Clinical Trials Logistics conference. “As we do more and more global studies, it’s really important to learn from what others have done right and wrong.”

The Clinical Trial Logistics conference showcases best practices from clinical logistic experts for streamlining logistics and overcoming inefficiencies, including:

• Optimizing Clinical Supply Chains: Creating efficiencies and developing successful vendor relationships
• Effective Clinical Logistics Risk Mitigation Strategies: Due diligence in emerging markets and considerations between internal vs. external manufacturing
• Storage, Packaging and Transport Solutions for Accelerating Clinical Logistics: Efficient, on-time shipments and effectively addressing challenges
• Investigating the Global Clinical Trials Regulatory Landscape: Complying with US standards and customs issues for import/export procedures

Steve recently spoke with IQPC on their Blog Talk Radio Show and commented on the importance of understanding regulations and logistics challenges in each country, specifically emerging countries. “If you actually take a look at just the regulatory requirements, they are taking in the vicinity of 44 weeks from the time you start putting together the regulatory documents to the time you can actually ship clinical supplies into the country.”

Steve will present a session titled How to Avoid Common Mistakes and Pitfalls for Clinical Trial Logistics Challenges in Emerging Countries on Wednesday, December 4, 2009.

Other speakers at the Clinical Trials Logistics conference include the Food & Drug Administration, Department of Homeland Security, Sanofi-Aventis, Pfizer, AstraZeneca, Merck, GlaxoSmithKline, Human Genome Sciences, Schering Plough.

For more information on the Clinical Trials Logistics conference contact Simon Curtis, Conference Director at [e-mail] or visit www.clinicaltrialslogistics.com.

About IQPC

IQPC (www.iqpc.com) provides business executives with tailored practical conferences, large-scale events, topical seminars and in-house training programs. Producing over 1,500 events annually around the world, IQPC continues to grow and has offices in cities across six continents including: Berlin, Dubai, London, New York, Sao Paulo, Singapore, Stockholm, Sydney, and Toronto.